Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis (original) (raw)

You do not currently have access to this article.

Purchase

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis - 24 Hours access

EUR €58.00

GBP £50.00

USD $62.00

Rental

This article is also available for rental through DeepDyve.

Advertisement intended for healthcare professionals